Encompass Health reports results for third quarter 2026
Encompass Health reported Q3 2026 revenue of $1.61 billion, up 8.9% year-over-year, with adjusted EPS of $1.52, up 23.6%, and Adjusted EBITDA of $346.6 million, up 15.5%. Adjusted free cash flow jumped 51.2% to $263.4 million, and same-store discharges grew 3.0% with net patient revenue per discharge up 4.0% to $22,543. The company raised full-year 2026 guidance across revenue ($6,450-$6,500M), Adjusted EBITDA ($1,395-$1,415M), and adjusted EPS ($6.23-$6.37).
Key figures
- Eps
- 1.51
- Guidance
- FY2026: revenue $6,450-$6,500M (from $6,410-$6,490M); Adjusted EBITDA $1,395-$1,415M (from $1,365-$1,395M); adjusted EPS from continuing operations $6.23-$6.37 (from $6.02-$6.25)
- Revenue Yoy
- 8.9%
- Discharges
- 69605
- Adjusted eps
- 1.52
- Adjusted fcf
- 263400000
- Adjusted ebitda
- 346600000
- Adjusted fcf yoy
- 51.2%
- Adjusted ebitda yoy
- 15.5%
- Operating cash flow
- 362000000
- Same store discharge growth
- 3.0%
- Net patient revenue per discharge
- 22543
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.